Tioga Pharmaceuticals
San Diego, California, United States
About Tioga Pharmaceuticals
Tioga Pharmaceuticals, Inc. develops therapies for the treatment of gastrointestinal diseases. Its product includes asimadoline, an orally administered small molecule therapeutic for the treatment of irritable bowel syndrome and functional dyspepsia. The company was founded in 2005 and is based in San Diego, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $57.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Apr 2012)
- Website: tiogapharma.com
- Phone: +1-858-677-6077
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/tioga-pharmaceuticals-2530428 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.